#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Mapping Antibody Epitopes of the Avian H5N1 Influenza Virus


article has not abstract


Vyšlo v časopise: Mapping Antibody Epitopes of the Avian H5N1 Influenza Virus. PLoS Med 6(4): e32767. doi:10.1371/journal.pmed.1000064
Kategorie: Perspective
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000064

Souhrn

article has not abstract


Zdroje

1. LukeTC

KilbaneEM

JacksonJL

HoffmanSL

2006 Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment? Ann Intern Med 145 599 609

2. ZhouB

ZhongN

GuanY

2007 Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357 1450 1451

3. SimmonsCP

BernasconiNL

SuguitanALJr.

MillsK

WardJM

2007 Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med 4 e178 doi:10.1371/journal.pmed.0040178

4. KashyapAK

SteelJ

OnerAF

DillonMA

SwaleRE

2008 Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A 105 5986 5991

5. Barbey-MartinC

GigantB

BizebardT

CalderLJ

WhartonSA

2002 An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294 70 74

6. YodenS

KidaH

KuwabaraM

YanagawaR

WebsterRG

1986 Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody. Virus Res 4 251 261

7. KnossowM

GaudierM

DouglasA

BarrereB

BizebardT

2002 Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302 294 298

8. KidaH

WebsterRG

YanagawaR

1983 Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus. Arch Virol 76 91 99

9. MurphyBR

KaselJA

ChanockRM

1972 Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med 286 1329 1332

10. CouchRB

KaselJA

GerinJL

SchulmanJL

KilbourneED

1974 Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis 129 411 420

11. SchulmanJL

KhakpourM

KilbourneED

1968 Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol 2 778 786

12. WebsterRG

ReayPA

LaverWG

1988 Protection against lethal influenza with neuraminidase. Virology 164 230 237

13. GrebeKM

YewdellJW

BenninkJR

2008 Heterosubtypic immunity to influenza A virus: Where do we stand? Microbes Infect 10 1024 1029

14. BuiHH

PetersB

AssarssonE

MbawuikeI

SetteA

2007 Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci U S A 104 246 251

15. SkehelJJ

StevensDJ

DanielsRS

DouglasAR

KnossowM

1984 A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A 81 1779 1783

16. WileyDC

WilsonIA

SkehelJJ

1981 Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 373 378

17. CatonAJ

BrownleeGG

YewdellJW

GerhardW

1982 The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31 417 427

18. TsuchiyaE

SugawaraK

HongoS

MatsuzakiY

MurakiY

2001 Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J Gen Virol 82 2475 2484

19. KaverinNV

RudnevaIA

IlyushinaNA

VarichNL

LipatovAS

2002 Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J Gen Virol 83 2497 2505

20. KaverinNV

RudnevaIA

GovorkovaEA

TimofeevaTA

ShilovAA

2007 Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 81 12911 12917

21. KhuranaS

SuguitanALJr.

RiveraY

SimmonsCP

LanzavecchiaA

2009 Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 6 e1000049 doi:10.1371/journal.pmed.1000049

22. SandbulteMR

JimenezGS

BoonACM

SmithLR

TreanorJJ

2007 Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4 e59 doi:10.1371/journal.pmed.0040059

23. FanJ

LiangX

HortonMS

PerryHC

CitronMP

2004 Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22 2993 3003

24. FengJ

ZhangM

MozdzanowskaK

ZharikovaD

HoffH

2006 Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J 3 102

25. ThrosbyM

van den BrinkE

JongeneelenM

PoonLLM

AlardP

2008 Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3 e3942 doi:10.1371/journal.pone.0003942

26. SuiJ

HwangWC

PerezS

WeiG

AirdD

2009 Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16 265 273

27. EkiertDC

BhabhaG

ElsligerMA

FriesenRH

JongeneelenM

2009 Antibody recognition of a highly conserved influenza virus epitope. Science E-pub 26 February 2009. doi:10.1126/science.1171491

Štítky
Interné lekárstvo
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#